Joan Webster

Joan Webster

Auto-generated profile, based on publicly available information

Joan Webster

National Centre of Research Excellence in Nursing, Centre for Health Practice Innovation, Menzies Health Institute Queensland, Griffith University, 170 Kessels Road, Brisbane, Queensland, Australia, 4111

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2019 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
JWJoan Webster
Joan Webster
SOSonya Osborne
Sonya Osborne
CRClaire M Rickard
Claire M Rickard
NMNicole Marsh
Nicole Marsh

26 March 2019 in Cochrane Database of Systematic Reviews
Verified
Journal Article
Closed access
PDF file
JWJoan Webster
Joan Webster
ZLZhenmi Liu
Zhenmi Liu
GNGill Norman
Gill Norman
JDJo C Dumville
Jo C Dumville
LCLaura Chiverton
Laura Chiverton
WCWendy P Chaboyer
Wendy P Chaboyer

13 April 2010 in Australian and New Zealand Journal of Obstetrics and Gynaecology
Verified
Journal Article
Open access
PDF file
JWJoan Webster
Joan Webster
CNCatherine Nicholas
Catherine Nicholas
CVCatherine Velacott
Catherine Velacott
NCNoelle Cridland
Noelle Cridland
LFLisa Fawcett
Lisa Fawcett
Background:  There is increasing interest in measuring quality of life (QOL) in clinical settings and in clinical trials. None of the commonly used QOL instruments has been validated for use postnatally.Aim:  To assess the psychometric properties of the 26‐item WHOQOL‐BREF (short version of the World Health Organization Quality of Life assessment) among women following childbirth.Methods:  Using a prospective cohort design, we recruited 320 women within the first few days of childbirth. At six weeks postpartum, participants were asked to complete the WHOQOL‐BREF, the Edinburgh Postnatal Depression Index and the Australian Unity Wellbeing Index. Validation of the WHOQOL‐BREF included an analysis of internal consistency, discriminate validity, convergent validity and an examination of the domain structure.Results:  In all, 221 (69.1%) women returned their six‐week questionnaire. All domains of the WHOQOL‐BREF met reliability standards (alpha coefficient exceeding 0.70). The questionnaire discriminated well between known groups (depressed women and non‐depressed women. P ≤ 0.000) and demonstrated satisfactory correlations with the Australian Unity Wellbeing index (r ≥ 0.45). The domain structure of the WHOQOL‐BREF was also valid in this population of new mothers, with moderate‐to‐high correlation between individual items and the domain structure to which the items were originally assigned.Conclusion:  The WHOQOL‐BRF is a well‐accepted and valid instrument in this population and may be used in postnatal clinical settings or for assessing intervention effects in research studies.

17 October 2018 in Trials
Verified
Journal Article
Open access
PDF file
NMNicole Marsh
Nicole Marsh
JWJoan Webster
Joan Webster
ELEmily Larsen
Emily Larsen
JGJodie Genzel
Jodie Genzel
MCMarie Cooke
Marie Cooke
CRClaire M Rickard
Claire M Rickard
Peripheral intravenous catheters (PVCs) are essential invasive devices, with 2 billion PVCs sold each year. The comparative efficacy of expert versus generalist inserter models for successful PVC insertion and subsequent reliable vascular access is unknown. A single-centre, parallel-group, pilot randomised controlled trial (RCT) of 138 medical/surgical patients was conducted in a large tertiary hospital in Australia to compare PVC insertion by (1) a vascular access specialist (VAS) or (2) any nursing or medical clinician (generalist model). The primary outcome was the feasibility of a larger RCT as established by predetermined criteria (eligibility, recruitment, retention, protocol adherence). Secondary outcomes were PVC failure: phlebitis, infiltration/extravasation, occlusion, accidental removal or partial dislodgement, local infection or catheter-related bloodstream infection; dwell time; insertion success, insertion attempts; patient satisfaction; and procedural cost-effectiveness. Feasibility outcomes were achieved: 92% of screened patients were eligible; two patients refused participation; there was no attrition or missing outcome data. PVC failure was higher with generalists (27/50, 54%) than with VASs (33/69, 48%) (228 versus 217 per 1000 PVC days; incidence rate ratio 1.05, 95% confidence interval 0.61–1.80). There were no local or PVC-related infections in either group. All PVCs (n = 69) were successfully inserted in the VAS group. In the generalist group, 19 (28%) patients did not have a PVC inserted. There were inadequate data available for the cost-effectiveness analysis, but the mean insertion procedure time was 2 min in the VAS group and 11 min in the generalist group. Overall satisfaction with the PVC was measured on an 11-point scale (0 = not satisfied and 10 = satisfied) and was higher in the VAS group (n = 43; median = 7) compared to the generalist group (n = 20; median = 4.5). The multivariable model identified medical diagnosis and bed-bound status as being significantly associated with higher PVC failure, and securement with additional non-sterile tape was significantly associated with lower PVC failure. This pilot trial confirmed the feasibility and need for a large, multicentre RCT to test these PVC insertion models. Australian New Zealand Clinical Trials Registry, ACTRN12616001675415 . Registered on 6 December 2016.

29 May 2014 in Australian Health Review
Verified
Journal Article
Closed access
PDF file
KNKaren A. New
Karen A. New
JWJoan Webster
Joan Webster
NMNicole M. Marsh
Nicole M. Marsh
BHBarbara Hewer
Barbara Hewer
Objective: To examine the use, management, documentation and complications for intravascular devices in cardiac, medical and surgical inpatients. Methods: A point prevalence survey was undertaken in a large tertiary hospital in Queensland. Descriptive statistics were used to analyse data. Results: Of the 327 patients assessed, 192 (58.7%) had one or more devices in situ. Of the 220 devices, 190 (86.4%) were peripheral venous catheters, 25 (11.4%) were peripherally inserted central catheters and five (2.3%) were central venous catheters. Sixty-two of 220 devices (28.2%) were in situ without a clear purpose, whereas 54 (24.7%) had one or more complications, such as redness, pain, tracking, oedema or oozing. There was no documentation on the daily patient care record to indicate that a site assessment had occurred within the past 8 h for 25% of the devices in situ. Conclusions: The present study identified several problems and highlighted areas for improvement in the management and documentation for intravascular devices. Ongoing education, promoting good clinical practice and reauditing, can be applied to improve the management of devices. What is known about the topic?: Intravascular devices are associated with health care-related infections, including rare but serious bloodstream infections Measures for reducing healthcare-associated infection related to devices include surveillance with feedback. What does this paper add?: This paper complements other surveillance data undertaken in similar-sized institutions with similar patients. Ongoing surveillance and education is required to maintain best clinical practice and management of devices. What are the implications for practitioners?: Health care-associated infections are a serious problem and have negative outcomes for both patients and organisations. Intravascular devices may be associated with bloodstream infections, so prudent clinical care and management of devices is important. All devices should be assessed at least daily for their continued need and removed promptly if no longer required.

30 September 2014 in Healthcare
Verified
Journal Article
Open access
PDF file
WCWendy Chaboyer
Wendy Chaboyer
VAVinah Anderson
Vinah Anderson
JWJoan Webster
Joan Webster
ASAnne Sneddon
Anne Sneddon
LTLukman Thalib
Lukman Thalib
BGBrigid M. Gillespie
Brigid M. Gillespie
Obese women undergoing caesarean section (CS) are at increased risk of surgical site infection (SSI). Negative Pressure Wound Therapy (NPWT) is growing in use as a prophylactic approach to prevent wound complications such as SSI, yet there is little evidence of its benefits. This pilot randomized controlled trial (RCT) assessed the effect of NPWT on SSI and other wound complications in obese women undergoing elective caesarean sections (CS) and also the feasibility of conducting a definitive trial. Ninety-two obese women undergoing elective CS were randomized in theatre via a central web based system using a parallel 1:1 process to two groups i.e., 46 women received the intervention (NPWT PICO™ dressing) and 46 women received standard care (Comfeel Plus® dressing). All women received the intended dressing following wound closure. The relative risk of SSI in the intervention group was 0.81 (95% CI 0.38–1.68); for the number of complications excluding SSI it was 0.98 (95% CI 0.34–2.79). A sample size of 784 (392 per group) would be required to find a statistically significant difference in SSI between the two groups with 90% power. These results demonstrate that a larger definitive trial is feasible and that careful planning and site selection is critical to the success of the overall study.